Ann Gidner - Ziccum AB Chief Officer
| ZICC Stock | SEK 0.25 0.00 0.00% |
Insider
Ann Gidner is Chief Officer of Ziccum AB
| Age | 57 |
| Phone | 46 7 09 61 55 99 |
| Web | https://ziccum.com |
Ziccum AB Management Efficiency
The company has return on total asset (ROA) of (0.5157) % which means that it has lost $0.5157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9753) %, meaning that it generated substantial loss on money invested by shareholders. Ziccum AB's management efficiency ratios could be used to measure how well Ziccum AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Associate Woldbye | Combigene AB | 60 | |
| Pr Gellerfors | BioArctic AB | 76 | |
| Christian Lindholm | Acarix AS | 59 | |
| Oskar Bosson | BioArctic AB | 47 | |
| Pr Kokaia | Combigene AB | 67 | |
| Louise Aspenberg | Combigene AB | 47 | |
| Peter Ekolind | Combigene AB | 59 | |
| Marianne Norskov | Acarix AS | 45 | |
| Christer Mller | BioArctic AB | 64 | |
| Karin Agerman | Combigene AB | 50 | |
| Tobias Fritz | Acarix AS | 44 | |
| Gunilla Andersson | BioArctic AB | 62 | |
| Johanna Flting | BioArctic AB | 51 | |
| Jan Mattsson | BioArctic AB | 63 | |
| Pr Lannfelt | BioArctic AB | 74 | |
| Thomas Lundstrm | Acarix AS | 49 | |
| Helen Round | Acarix AS | 59 | |
| Gunilla Osswald | BioArctic AB | 62 | |
| Anders Krabbe | Acarix AS | 56 | |
| Frida Lekander | BioArctic AB | N/A | |
| Harald Borgeke | BioArctic AB | N/A | |
Management Performance
| Return On Equity | -0.98 | |||
| Return On Asset | -0.52 |
Ziccum AB Management Team
Elected by the shareholders, the Ziccum AB's board of directors comprises two types of representatives: Ziccum AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ziccum. The board's role is to monitor Ziccum AB's management team and ensure that shareholders' interests are well served. Ziccum AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ziccum AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frida Hjelmberg, Chief Officer | ||
| Fabrice Rose, Scientific Director | ||
| Ann Gidner, Chief Officer |
Ziccum Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ziccum AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.98 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 2.01 M | |||
| Shares Outstanding | 13.81 M | |||
| Shares Owned By Insiders | 25.53 % | |||
| Price To Book | 0.81 X | |||
| Price To Sales | 2,383 X | |||
| Gross Profit | 17 K | |||
| EBITDA | (20.27 M) | |||
| Net Income | (21.14 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ziccum Stock Analysis
When running Ziccum AB's price analysis, check to measure Ziccum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ziccum AB is operating at the current time. Most of Ziccum AB's value examination focuses on studying past and present price action to predict the probability of Ziccum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ziccum AB's price. Additionally, you may evaluate how the addition of Ziccum AB to your portfolios can decrease your overall portfolio volatility.